Gerald A. Faich

6.8k total citations · 1 hit paper
75 papers, 5.0k citations indexed

About

Gerald A. Faich is a scholar working on Toxicology, Pediatrics, Perinatology and Child Health and Economics and Econometrics. According to data from OpenAlex, Gerald A. Faich has authored 75 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Toxicology, 14 papers in Pediatrics, Perinatology and Child Health and 10 papers in Economics and Econometrics. Recurrent topics in Gerald A. Faich's work include Pharmacovigilance and Adverse Drug Reactions (24 papers), Pharmaceutical studies and practices (12 papers) and Pharmaceutical industry and healthcare (7 papers). Gerald A. Faich is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (24 papers), Pharmaceutical studies and practices (12 papers) and Pharmaceutical industry and healthcare (7 papers). Gerald A. Faich collaborates with scholars based in United States, Sweden and Switzerland. Gerald A. Faich's co-authors include Robert Makuch, Andrew Whelton, Gilbert Geis, J B Lefkowith, Kenneth M. Verburg, Theodore Pincus, William F. Stenson, N M Agrawal, Fred E. Silverstein and Aimee Burr and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Gerald A. Faich

75 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis

2000 2.4k citations Fred E. Silverstein, Gerald A. Faich et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gerald A. Faich United States	29	2.5k	899	821	468	439	75	5.0k
C J Hawkey United Kingdom	44	2.2k 0.9×	906 1.0×	3.1k 3.8×	275 0.6×	861 2.0×	170	7.2k
Alise Reicin United States	27	3.8k 1.5×	1.4k 1.5×	1.2k 1.5×	136 0.3×	463 1.1×	39	5.7k
Susana Perez‐Gutthann United States	30	1.4k 0.6×	864 1.0×	848 1.0×	215 0.5×	445 1.0×	80	5.1k
Gurkirpal Singh United States	43	2.9k 1.2×	853 0.9×	1.9k 2.4×	1.1k 2.3×	335 0.8×	122	8.0k
M. J. S. Langman United Kingdom	45	2.1k 0.9×	717 0.8×	3.0k 3.6×	129 0.3×	962 2.2×	168	7.1k
E A Roberts Canada	19	2.1k 0.9×	738 0.8×	1.4k 1.8×	521 1.1×	591 1.3×	34	9.5k
Andrew Whelton United States	35	4.8k 2.0×	1.9k 2.1×	1.8k 2.2×	103 0.2×	498 1.1×	149	8.3k
Hillel Halkin Israel	39	474 0.2×	1.4k 1.6×	610 0.7×	215 0.5×	244 0.6×	128	5.4k
Jay L. Goldstein United States	43	3.8k 1.6×	1.5k 1.6×	4.2k 5.2×	104 0.2×	455 1.0×	158	9.3k
Neville D. Yeomans Australia	39	2.0k 0.8×	773 0.9×	3.2k 3.9×	75 0.2×	254 0.6×	158	5.5k

Countries citing papers authored by Gerald A. Faich

Since Specialization

Citations

This map shows the geographic impact of Gerald A. Faich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald A. Faich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald A. Faich more than expected).

Fields of papers citing papers by Gerald A. Faich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald A. Faich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald A. Faich. The network helps show where Gerald A. Faich may publish in the future.

Co-authorship network of co-authors of Gerald A. Faich

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald A. Faich. A scholar is included among the top collaborators of Gerald A. Faich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald A. Faich. Gerald A. Faich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Strom, Brian L., Sybil M. Eng, Gerald A. Faich, et al.. (2010). Comparative Mortality Associated With Ziprasidone and Olanzapine in Real-World Use Among 18,154 Patients With Schizophrenia: The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC). American Journal of Psychiatry. 168(2). 193–201. 77 indexed citations

Kane, John M., Brian L. Strom, Sybil M. Eng, et al.. (2010). PRIMARY AND READJUDICATION MORTALITY RESULTS FROM ZODIAC, A LARGE SIMPLE TRIAL OF ZIPRASIDONE VS. OLANZAPINE IN PATIENTS WITH SCHIZOPHRENIA. Schizophrenia Research. 117(2-3). 183–184. 1 indexed citations

Faich, Gerald A., et al.. (2008). The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC). The Journal of Clinical Psychiatry. 69(1). 114–121. 20 indexed citations

Johannes, Catherine B., et al.. (2007). Incidence of Allergic Reactions Associated with Antibacterial Use in a Large, Managed Care Organisation. Drug Safety. 30(8). 705–713. 65 indexed citations

Edwards, Ralph, Gerald A. Faich, & Hugh A. Tilson. (2005). Points to consider: the roles of surveillance and epidemiology in advancing drug safety. Pharmacoepidemiology and Drug Safety. 14(9). 665–667. 8 indexed citations

White, William B., Gerald A. Faich, Jeffrey Borer, & Robert Makuch. (2003). Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib**The investigators had full access to the data and complete control over the design, conduct analysis, interpretation, and description of the study. The sponsor of the study had no role in study design, data collection, data analysis, data interpretation, or in writing the report. The views expressed are those of the investigators alone.. The American Journal of Cardiology. 92(4). 411–418. 147 indexed citations

Feldman, Harold I., Jill Santanna, Wensheng Guo, et al.. (2002). Iron Administration and Clinical Outcomes in Hemodialysis Patients. Journal of the American Society of Nephrology. 13(3). 734–744. 119 indexed citations

Faich, Gerald A. & Richard H. Moseley. (2001). Troglitazone (Rezulin) and hepatic injury. Pharmacoepidemiology and Drug Safety. 10(6). 537–547. 34 indexed citations

Silverstein, Fred E., Gerald A. Faich, Jay L. Goldstein, et al.. (2000). Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis. JAMA. 284(10). 1247–1247. 2401 indexed citations breakdown →

10.

Drake, L A, et al.. (1998). Effect of onychomycosis on quality of life. Journal of the American Academy of Dermatology. 38(5). 702–704. 110 indexed citations

11.

Faich, Gerald A.. (1995). FDA and Drug Approval. Journal of Vascular and Interventional Radiology. 6(6). 24S–24S. 1 indexed citations

12.

Faich, Gerald A.. (1993). Phase IIIB and Treatment IND Safety Reporting. Drug Information Journal. 27(4). 1173–1177. 1 indexed citations

13.

Bergman, Ulf, et al.. (1992). Effects of exposure to benzodiazepine during fetal life. The Lancet. 340(8821). 694–696. 64 indexed citations

14.

Jolson, Heidi M., Laura Bosco, B. Burt Gerstman, et al.. (1992). Clustering of Adverse Drug Events: Analysis of Risk Factors for Cerebellar Toxicity With High-Dose Cytarabine. JNCI Journal of the National Cancer Institute. 84(7). 500–505. 13 indexed citations

15.

Kennedy, Dianne L., et al.. (1990). FDA-State Projects to Improve Reporting of Adverse Drug Reactions. 8(1). 5–12. 2 indexed citations

16.

Baum, Carlene, et al.. (1988). Prescription Drug Use in 1984 and Changes Over Time. Medical Care. 26(2). 105–114. 47 indexed citations

17.

Faich, Gerald A., et al.. (1986). Toxic shock syndrome and the vaginal contraceptive sponge.. PubMed. 255(2). 216–8. 25 indexed citations

18.

Faich, Gerald A.. (1985). International Drug Surveillance. Drug Information Journal. 19(3). 227–229. 1 indexed citations

19.

Dennehy, Penelope H. & Gerald A. Faich. (1982). Pneumococcal pneumonia in Rhode Island: Implications for vaccine use. Journal of Infection. 4(3). 229–235. 2 indexed citations

20.

Faich, Gerald A., et al.. (1973). The rise and fall of Shiga dysentery in El Salvador, 1969-1973.. 7(4). 20–24. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact